MARKET

LABU

LABU

Direxion Daily S&P Biotech Bull 3X ETF
NYSEARCA
146.16
+2.31
+1.61%
After Hours: 145.64 -0.52 -0.35% 19:59 07/26 EDT
OPEN
148.70
PREV CLOSE
143.85
HIGH
152.60
LOW
143.65
VOLUME
1.75M
TURNOVER
0
52 WEEK HIGH
176.99
52 WEEK LOW
48.18
TOTAL ASSET
1.24B
YTD YIELD
24.47%
1D
5D
1M
3M
1Y
5Y
1D
Buy LABU: Biotech Sector Benefits From Lower Interest Rates And AI
Buy LABU: Biotech Sector Benefits From Lower Interest Rates And AI. Markets expect the first interest rate cut at the September Fed meeting. Direxion Daily S&P Biotech Bull 3X Shares ETF has strong momentum and benefits from lower interest rates. The fund is expected to make big gains in the second half of the year.
Seeking Alpha · 4d ago
Weekly Report: what happened at LABU last week (0715-0719)?
Weekly Report · 4d ago
ASCO Annual Meeting 2024: Breakthrough Treatments Hint At Renewed Hope For Patients And Investors
Seeking Alpha · 07/17 08:42
5 Top-Performing Inverse/Leveraged ETFs of Last Week
NASDAQ · 07/16 12:00
Weekly Report: what happened at LABU last week (0708-0712)?
Weekly Report · 07/15 10:54
Weekly Report: what happened at LABU last week (0701-0705)?
Weekly Report · 07/08 10:55
Weekly Report: what happened at LABU last week (0624-0628)?
Weekly Report · 07/01 10:56
UDOW And Leveraged ETFs Dashboard For July
ProShares UltraPro Dow30 ETF (UDOW) is a popular instrument to trade in bullish market conditions. Leveraged ETFs often underperform their underlying index, mostly due to beta-slippage. Historical data reveal a negative average drift and underwhelming performance over the last 5 years.
Seeking Alpha · 07/01 10:00
More
Profile
Fund Name
Direxion Daily S&P Biotech Bull 3X ETF
Inception Date
2015-05-28
Benchmark
S&P Biotechnology Select Industry TR USD
Advisor Company
Rafferty Asset Management LLC
Custodian
Bank of New York Mellon
Manager
Tony Ng, Paul Brigandi